Large pharma runs Microsoft 365 / Teams. Biotech startups and CROs run Slack. SyncRivo bridges the split — FDA 21 CFR Part 11-supportive, HIPAA BAA available, per-study channel isolation.
The Teams↔Slack divide in life sciences is the most predictable of any industry — it maps almost exactly onto company size and vintage.
Microsoft Teams
Large Pharma Layer
Slack
Biotech & Innovation Layer
Pharma M&A is among the highest-frequency use cases for SyncRivo. Pfizer/Seagen, AstraZeneca/Alexion, Merck/Prometheus — in virtually every deal, the acquiree is on Slack and the acquirer is on Teams. Both organizations need to communicate from day one while IT determines the long-term platform strategy. SyncRivo bridges both in under 20 minutes per channel pair with no migration required.
ICON, IQVIA, PRA Health Sciences, and Covance operate their own enterprise messaging environments. SyncRivo creates per-CRO, per-study bridges — each clinical partner gets an isolated channel bridge to the sponsor's study coordination channels. Per-study isolation ensures communications for one trial do not cross into another study's channels. No guest accounts required.
Veeva Vault fires document lifecycle events and study workflow alerts to Slack natively — there is no native Veeva → Teams integration. For large pharma where regulatory affairs and medical affairs teams use Teams, SyncRivo routes those Slack Veeva alerts to Teams in real time. Single event, multiple destinations, without duplicating Veeva configuration.
Pharmaceutical co-development agreements and licensing deals require sustained cross-company communication between organizations on different platforms. SyncRivo creates per-alliance channel bridges — joint project teams communicate in real time from their native platform while per-alliance isolation keeps each partnership's communications separate from internal channels.
Pharmaceutical communications span FDA-regulated environments, HIPAA-covered PHI, and GxP requirements. SyncRivo's architecture is designed for these requirements.
Annual third-party audit across security, availability, and confidentiality. Covers the controls relevant to FDA 21 CFR Part 11 audit trail requirements.
Business Associate Agreement available on the Enterprise plan for clinical trial and patient-adjacent communications involving Protected Health Information.
Message content never persists on SyncRivo infrastructure. Messages route through the event pipeline and are delivered directly to destination APIs — consistent with FDA 21 CFR Part 11 data integrity principles.
All data in transit is encrypted with TLS 1.3. No plaintext message data traverses SyncRivo infrastructure — relevant to GxP data integrity requirements.
Each organization's and each study's bridge configuration, tokens, and routing rules are fully isolated. No cross-tenant data leakage. Per-study channel isolation for clinical trial communications.
Message routing events are logged with immutable audit trails on the Enterprise plan — supports 21 CFR Part 11 audit trail requirements for regulated communications.
Microsoft Teams
Large pharma corporate
Slack
Biotech & CRO teams
Google Chat
Research & academic partners
Zoom Team Chat
Remote clinical sites
Cisco Webex
Cisco-standardized CROs
SyncRivo vs Mio
Mio has no Webex support and no HIPAA BAA — critical gaps for pharma and clinical trial environments.
SyncRivo vs ChatBridge
ChatBridge lacks HIPAA attestation and Google Chat support for R&D and CRO collaboration.
SyncRivo vs NextPlane
NextPlane is Teams↔Google Chat only — misses Webex used by large pharma and Slack used by biotech.
Reference
5×5 Messaging Platform Compatibility Matrix — all 10 pairs
Zero native cross-platform messaging between any pair. SyncRivo bridges all 10.
Connect Teams, Slack, Zoom, Google Chat, and Webex. HIPAA BAA available. FDA 21 CFR Part 11-supportive architecture. Zero message storage.
Connection setup: Slack ↔ Teams step-by-step